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Abstract
Background: There has been a growing interest in the role of the private for-profit sector in health
service provision in low- and middle-income countries. The private sector represents an important source
of care for all socioeconomic groups, including the poorest and substantial concerns have been raised
about the quality of care it provides. Interventions have been developed to address these technical failures
and simultaneously take advantage of the potential for involving private providers to achieve public health
goals. Limited information is available on the extent to which these interventions have successfully
expanded access to quality health services for poor and disadvantaged populations. This paper addresses
this knowledge gap by presenting the results of a systematic literature review on the effectiveness of
working with private for-profit providers to reach the poor.
Methods: The search topic of the systematic literature review was the effectiveness of interventions
working with the private for-profit sector to improve utilization of quality health services by the poor.
Interventions included social marketing, use of vouchers, pre-packaging of drugs, franchising, training,
regulation, accreditation and contracting-out. The search for published literature used a series of
electronic databases including PubMed, Popline, HMIC and CabHealth Global Health. The search for grey
and unpublished literature used documents available on the World Wide Web. We focused on studies
which evaluated the impact of interventions on utilization and/or quality of services and which provided
information on the socioeconomic status of the beneficiary populations.
Results: A total of 2483 references were retrieved, of which 52 qualified as impact evaluations. Data were
available on the average socioeconomic status of recipient communities for 5 interventions, and on the
distribution of benefits across socioeconomic groups for 5 interventions.
Conclusion: Few studies provided evidence on the impact of private sector interventions on quality and/
or utilization of care by the poor. It was, however, evident that many interventions have worked
successfully in poor communities and positive equity impacts can be inferred from interventions that work
with types of providers predominantly used by poor people. Better evidence of the equity impact of
interventions working with the private sector is needed for more robust conclusions to be drawn.
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Background
Recent years have seen increasing interest in the role of the
private sector in health service provision in low- and mid-
dle-income countries. Many countries have a vibrant and
growing private sector, which is perceived by some to
respond to public sector failures. Private providers are
argued to deliver services which are more accessible,
affordable (particularly where public providers charge
official or unofficial user fees) and responsive to the needs
and preferences of users [1].
The private sector is also an important source of care for
poor and disadvantaged groups within low- and middle-
income countries. For instance, in Guatemala, 40 to 45%
of the population in the two lower income quintiles
sought care in the private sector and in South Africa over
33% of each of the three lower quintiles did so [2]. Simi-
larly, in Nepal, the private sector provided care to more
than a third of the lowest income quartile [3]. A review of
Demographic Health Survey (DHS) data from 38 coun-
tries found high levels of private sector use by those in the
lowest socioeconomic quintile for childhood diarrhea
(34–96% of children) and acute respiratory infections
(37–99% of children) [4]. In seeking to extend coverage of
priority interventions, there are numerous operational
advantages to working with pre-existing, self-sustaining
outlets that are widely used by target populations. For
these reasons the private sector represents an important
potential partner in efforts to scale up coverage of effective
health interventions among the poor.
However, there is a growing body of evidence that the care
provided in the private sector is often of low technical
quality [5]. For example, private sector treatment of sexu-
ally transmitted infections (STIs) [6], tuberculosis [7] and
malaria [8] have been demonstrated to have significant
shortcomings in terms of quality of diagnosis and correct
prescription of medications. Concern about the potential
harm caused by private providers, combined with recog-
nition that public sector technical quality is often also
poor, has led to interest in developing interventions
which will take advantage of the potential offered by the
private sector while at the same time addressing its techni-
cal failures. There is now a substantial literature on ways
that government and non-governmental organizations
(NGOs) can work with private health care providers,
including social marketing, regulation, training, franchis-
ing, accreditation and contracting-out [1,4,5,8-11].
It has been argued that there is "evidence that effective
public-private partnerships can increase access, improve
equity, and raise quality of health services"[12] and that
governments should "urgently engage with private stake-
holders to. .... facilitate increased private sector participa-
tion" [12]. However, the case that private sector
interventions improve equity has not yet been clearly
made [13]. Moreover, one might fear that working with
private for-profit providers may disproportionately bene-
fit the wealthier members of the community who can
afford their charges, and thus exacerbate inequity [14].
This paper addresses this knowledge gap by presenting the
results of a systematic review of the impact of private sec-
tor interventions on the poor. Section 1 sets the scope of
the literature review, providing definitions of key terms
and concepts and describes the review methods. Section 2
presents the findings, which are discussed in the final sec-
tion.
Methods
The scope of the review was defined as follows:
Scope of the review
Private sector
The private health sector is commonly defined as all pro-
viders outside the public sector. This includes a heteroge-
neous mix of for-profit and not-for profit providers, with
varying degrees of formality and qualifications. Our focus
was on interventions that work with existing for-profit
providers, both formal and informal. While we recognize
the importance of private not-for-profit providers, their
characteristics and incentives are likely to differ from
those of commercial providers, and they were considered
beyond the scope of this review. In practice, boundaries
between public and private provision may be blurred;
both formal and informal cost recovery schemes operate
at public facilities [15] and dual practice, where providers
work in both the public and private sectors, is widespread
[16]. We have not set out to include these mixes of public
and private operations, though it is possible that some
private outlets involved in the reviewed interventions are
run by public sector staff.
Health services and public health products
In this paper, health services refer to all in-patient and
ambulatory care services [17], and public health products
are "those commodities used for treatment of diseases of
public health importance or for the promotion of health,
which can be provided at the retail level without a 'service'
attached to them" [18]. Examples of the latter include
condoms and mosquito nets. We addressed only those
services and interventions which fall under the classifica-
tion of biomedical/allopathic, and excluded interventions
to improve the quality of "traditional" care.
Outcome Measures
We included studies focusing on the impact on either uti-
lization or quality of care. We focused on utilization
because it reflects the degree to which multiple barriers to
access (e.g. geographic, financial, social) are overcome. In
terms of quality, our focus was on both the technical andInternational Journal for Equity in Health 2007, 6:17 http://www.equityhealthj.com/content/6/1/17
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perceived dimensions of quality. We considered technical
quality to be assessed through observation of provider
behaviour and of the physical attributes of the practice
[18]. For example, we included studies that evaluated pro-
viders' practical performance against training or national
guidelines (e.g. proportion of cases correctly managed),
and those that assessed the adequacy of the premises for
the services and products provided (e.g. range of essential
drugs available). We also included studies on the more
controversial dimension of quality based on patients' per-
ceptions and considered perceived quality as measured by
the level of satisfaction expressed by patients. Our review
excluded studies that reported intervention impacts in
terms of providers' qualifications and knowledge alone.
Private sector interventions
A preliminary review identified eight areas of intervention
involving the government or NGOs working with the pri-
vate for-profit sector: social marketing, use of vouchers,
pre-packaging of drugs, franchising, training, regulation,
accreditation and contracting-out.
Social marketing is the application of the tools and con-
cepts of commercial marketing to social and health prob-
lems [19], in order to increase population coverage of
effective and affordable interventions [10]. Social market-
ing interventions may include a combination of promo-
tional activities, branding, labelling, pre-packaging and
subsidy of public health products.
A voucher is a form of demand-side subsidy that the recip-
ient can use as part or full-payment for a product or service
from identified providers. The distribution of vouchers
can be targeted, to improve access for an identified popu-
lation group such as the poorest households or pregnant
women. Vouchers can either be competitively redeemed
where they are exchangeable at a number of different pro-
viders [10], or non-competitive where they are assigned to
one particular provider [9].
Pre-packaging is a strategy to improve provider and patient
adherence to treatment regimens, and involves packaging
drugs in pre-defined doses adequate for the targeted pop-
ulation group and length of treatment regimen [20].
A franchise is a contractual arrangement between a health
service provider and a franchise organisation. It aims to
improve access to quality- and price-controlled services.
Franchisees are trained in standardized practices for which
prices are predefined [21] and benefit from advertising of
the logo or franchise name. In return, franchisees may be
required to comply with minimum sales volume and
quality standards and pay a membership fee to the fran-
chisor [22]. Providers are monitored by the franchise
organisation, which in public health is generally a govern-
ment or donor-sponsored NGO which subsidises the net-
work [22].
Accreditation is a strategy to improve and control the qual-
ity of services provided at organisational or facility level
through oversight by an independent quality control eval-
uation body which may be the government or an NGO. It
may include training providers in standardised practices
[1]. While accreditation is similar to franchising, the
nature of the relationship between the provider/accreditor
is often voluntary, compared with the contractual rela-
tionship between the franchisee/franchise organization.
Training interventions can take various forms including
formal training sessions, vendor-to-vendor education, dis-
tribution of guidelines and job-aids. Training is often inte-
grated into other interventions, such as franchising,
accreditation and social marketing.
Regulatory  interventions aim to set up and ensure ade-
quate technical quality of the services provided [18]. They
take the form of rules, enforcement systems and sanction
mechanisms, and can be applied at the levels of health
care provider, organisation or facility. At the provider level
regulation may include requirements for pre-service train-
ing, continuing education, licensing and certification of
providers [23]. At the organisational or facility level, regu-
lation may aim to control the location of facilities, their
registration and minimum complement of staff or facili-
ties [18]. In addition, consumer protection legislation
may be used to oversee medical practices and influence
provider behaviour. Pharmaceutical market regulation
aims to limit the availability of harmful drugs and unreg-
istered products, minimize drug misuse, control the sale
of specific drugs through prescriptions, and regulate drug
manufacture and importation [20].
Contracting out is a purchasing mechanism used to acquire
specified services of a defined quality at an agreed price
from a specific private provider and for a specific period of
time. Governments may purchase clinical or non-clinical
services from private providers to complement public pro-
vision [24].
Where interventions employed a mix of strategies we clas-
sified them by the primary or main intervention, based on
the emphasis given in the paper or report.
Poverty
The main focus of this paper was the extent to which the
effects of private sector interventions reach the poor. Pov-
erty is a multidimensional construct, notoriously difficult
to measure [25]. Various tools are used to assess the pov-
erty status of population groups, in either absolute or rel-
ative terms. For instance, household income orInternational Journal for Equity in Health 2007, 6:17 http://www.equityhealthj.com/content/6/1/17
Page 4 of 11
(page number not for citation purposes)
consumption, asset ownership and housing conditions,
residence status and the level of education attained, are all
relevant dimensions. We included in the review all studies
that examined the effects of interventions on the poor as
measured by any of these indicators, for example those
with low household income, lower levels of education, or
those living in rural areas. It is recognised that all of these
proxies suffer from imperfections, in terms both of meas-
urement and interpretation [26,27].
To determine whether an intervention reaches the poor
we took two approaches. First, interventions were deemed
to have reached the poor if they benefited generally poor
areas based on the study site information provided in the
original papers. This was termed an average SES measure.
Secondly, interventions were deemed to have reached the
poor if the socioeconomic distribution of benefits
favoured the most disadvantaged groups within a given
population. This was termed a relative SES measure. The
distinction between these two criteria is important, and is
linked to the difference between measures of absolute and
relative poverty. For instance, an intervention that is
implemented among private providers in a predomi-
nantly rural district of a poor country may improve the
quality of care received by all socioeconomic groups in
that area (i.e. may have no effect on the relative distribu-
tion of access to quality services). However, because most
of the population is disadvantaged, it can be judged to be
successful in reaching the poor based on an average SES
measure. Alternatively, an intervention that generates a
greater improvement in utilization of quality care for
those in the lowest income quintile compared with the
highest, for example by targeting providers who are pref-
erentially used by the poorest, would be judged to have
reached the poor based on a relative SES measure.
Search methodology
Published, grey and unpublished literature was systemat-
ically searched. The search topic was defined as evidence
on the effectiveness of different strategies of working with
existing private-for-profit providers to improve utilization
and quality of health services and public heath products
for the poor.
The search for published literature used the electronic
databases PubMed, Popline, HMIC and CabHealth Glo-
bal Health applying both controlled vocabulary and free
text key terms, and limiting the review to articles pub-
lished after 1990, in English and French (Table 1).
The search for grey and unpublished literature focused on
reports and documents available on the World Wide Web.
Using key terms in Table 1, we searched the sites of Eldis
Gateway to Development Information, USAID PSP-One,
and World Bank Knowledge Services for Private Sector
Development. The bibliographies of selected papers were
also checked for additional papers.
When all searches were complete, document titles and
available abstracts were read and potential sources
selected based on the following inclusion criteria.
We included all impact evaluations of interventions work-
ing with private for-profit providers in low and middle-
income countries that measured the effect of the interven-
tion on either utilization or quality of services. An impact
evaluation was defined as a study documenting changes
over time (pre-post), or comparing an intervention area
with a control area (controlled), or comparing changes
over time in an intervention area with changes over time
in a control area (pre-post with control), with or without
randomisation. We excluded studies using national sur-
vey data on aggregate changes in utilization of a service or
a product that could not be related to a specific interven-
tion.
We then identified interventions with average socioeco-
nomic status (SES) information on the recipient popula-
tion, and those which documented relative effectiveness
across SES groups.
Table 1: Search strategy: key terms and limits
Key terms Limits
Private Sector* Geographic
Delivery of Health Care† Developing countries
Health Care Sector† Low income countries
Social marketing* Middle income countries
Marketing of health services† Linguistic
Voucher‡ English
Vouchers‡ French
Franchising‡ Publication period
Franchise‡ 01/1990 to 05/2006
Accreditation*
Accredited‡
Education, Pharmacy†
Training‡
Contracting out‡
Contract services‡
Contracting‡
Facility regulation and control ^†
Regulation‡
Drugs, Non-Prescription†
Antimalarials†
Drug Labeling†
Drug Packaging†
*MeSH and free text
† MeSH only
‡ free text only
^legislation and jurisprudence subheading onlyInternational Journal for Equity in Health 2007, 6:17 http://www.equityhealthj.com/content/6/1/17
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Results
A total of 2483 references were retrieved, from which 52
evaluated interventions working with private for-profit
providers were identified. The majority concerned train-
ing (26) and social marketing (14), with the remainder
evaluating contracting-out (3), franchising (6), regulation
(2) and accreditation (1) [see Additional file 1].
Social marketing, vouchers and pre-packaging of drugs
These interventions were grouped together because of
their significant overlap. Fourteen evaluated interventions
were identified, eleven relating to social marketing one
also including a voucher scheme, and 2 including pre-
packaged treatments. A further 3 interventions focused
purely on provision of vouchers.
Of the social marketing interventions, six involved con-
doms and/or other family planning commodities, and
one each involved oral rehydration therapy (ORT), iron
supplements, insecticide treated nets (ITNs), STI treat-
ment and malaria/acute respiratory infection (ARI) treat-
ment. All showed significant increases in utilization of
programme commodities and services, though of differ-
ing magnitudes across interventions. For example, social
marketing increased condom use among women in urban
Cameroon from 58% to 76% [28], coverage of iron-folic
acid supplementation from 6% to 99% in non-pregnant
Filipino women [29], and ITN coverage in rural Tanza-
nian children under 2 years from 10% to 61% [30].
The contraceptive social marketing programmes were
implemented in urban settings and the majority targeted
adolescent groups. A number of interventions included
peer educators as well as distribution of commodities
through retail outlets (Soweto, Horizon Jeunes, Tsa
Banana, My Future First).
The social marketing programme for ORT in a rural Ken-
yan district included sales of flavoured ORT sachets
through shops and a mass communication and education
campaign [31]. In the Philippines, social marketing of
iron and folic acid supplements in rural municipalities
combined free distribution of iron-folic acid supplemen-
tation targeted to pregnant women through the public
health system and sales of iron supplements to non-preg-
nant women by village health workers (VHWs) and drug
outlets, as well as training VHWs and school teachers in
counselling and information, education and communica-
tion (IEC) [29].
The Kilombero and Ulanga Insecticide-Treated Net
project (KINET) in Tanzania distributed branded ITNs
and net treatment kits through retail outlets, and included
a comprehensive IEC campaign [19,30,32-34]. Vouchers
reducing the price of nets at retail shops by 17% were dis-
tributed to pregnant women and mothers of under-five
children attending public clinics.
Vouchers for free nets and treatment from retail outlets
were used alongside measles vaccination in a campaign
approach in an urban Zambian district [35]. Two other
voucher schemes for sexual and reproductive health care
(SRHC) were implemented in Nicaragua. The first tar-
geted adolescent girls at various sites, entitling the recipi-
ent to free SRHC at NGO, public and for-profit clinics
[36,37]. The second scheme provided free STI care at pri-
vate for-profit and NGO clinics for sex workers and their
clients [38].
Two final interventions combined social marketing with
prepackaged treatments – for STI treatment for male ure-
thritis in Uganda [39] and prepackaged treatment for
childhood malaria and acute respiratory infections in
Nigeria [40].
Of the 14 interventions, data on the average SES of the
recipient community was provided for only one, the
KINET ITN project. This clearly benefited a generally poor
population, with an estimated median household
monthly expenditure of $77–96 in 1997 [34]. For 12
interventions, only general information on the urban/
rural settings was available, and for 1 intervention there
was no information aside from location.
Data on the distribution of benefits across socioeconomic
groups was provided for 2 of these interventions. The
effect of KINET on the socioeconomic distribution of ITNs
was documented in three studies. The first demonstrated
positive changes in the ratio of net ownership in the low-
est to the highest SES quintiles (the equity ratio) from 0.3
in 1997 to 0.6 in 2000 [33]. The second reported a signif-
icantly greater increase (of 51%) in household net owner-
ship among the poorest income quartile in the social
marketing area compared to 32% in the control area. Sim-
ilar information for households in village peripheries
(likely to be poorer) were 68% and 27% [19]. The third
study assessed the socioeconomic distribution of vouch-
ers and, in contrast to the other two, found that none of
the households in the lowest quintile had used a voucher
towards the purchase of a net compared to 8% in the high-
est quintile [32]. This may be due to the low share of
vouchers in total net sales, itself reflecting low knowledge
among mothers of vouchers, with only 28% of women
having ever heard of the voucher scheme [41].
Poorer groups also benefited in relative terms in urban
Zambia, where the equity ratio for ITN coverage increased
from 0.66 to 1.19, with no statistically significant associa-
tion between wealth and ownership found post-interven-
tion [35].International Journal for Equity in Health 2007, 6:17 http://www.equityhealthj.com/content/6/1/17
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Regulation
Of the two evaluated interventions identified, one con-
cerned banning a drug and its combination products in
Nepal and one assessed a regulatory intervention to
improve quality of pharmacy services in Lao P.D.R.
The pharmaceutical ban prohibited the export, import,
local production, transportation, storage, sale and distri-
bution of Analgin (an analgesic and antipyretic drug) and
its combination products [42]. As a result, the proportion
of retail outlets with Analgin decreased from 96.5% at
baseline to 21.2% five months after the intervention and
0% sixteen months after [42].
The regulatory intervention in Lao P.D.R involved inten-
sive supervision of the quality of pharmacy services,
applying sanctions when rules were violated, and provid-
ing up-to-date regulatory documents and information
about particular areas needing improvements [43]. The
study compared districts with intensified regulation with
normal, control districts. Whilst it could not be estab-
lished that the intensive intervention had a greater effect
than routine regulation, moderate but significant
improvements in quality were observed in all districts,
with mean availability of essential materials increasing by
34% and mean order in the pharmacy (including the pres-
ence of advertisements, and whether drugs were stored in
their original packaging away from sunlight) increasing
by 19% [43].
For these two interventions, no SES information was pro-
vided about the recipient populations.
Training
Training was by far the most evaluated intervention, with
26 interventions covering different types of private pro-
viders: 4 targeted private doctors, 2 private midwives, 8
private pharmacy workers, 6 drug retailers and 6 a mix of
provider types. Training interventions aimed to improve
the quality of treatment of a range of different conditions.
Seven interventions focused on treatment of childhood
illness (use of integrated management of childhood ill-
ness (IMCI) guidelines, treatment of ARI or diarrhea); 5
addressed quality of STI treatment; 5 the quality of family
planning or reproductive health services; 4 malaria treat-
ment; and the remaining studies addressed other commu-
nicable diseases (e.g. ARIs), or multiple diseases (e.g. "6
common illnesses").
Most interventions produced positive results for at least
some outcome indicators. For instance, a study of the
Ghanaian intervention to improve STI management at
pharmacies, which evaluated outcomes using simulated
clients, found that when offered treatment, 38% of simu-
lated clients received appropriate oral medication at inter-
vention pharmacies compared with 18% at control
pharmacies. Counseling about partner notification was
40% in intervention pharmacies compared with 21% in
control pharmacies, though no recommendation to use a
condom was given at intervention pharmacies compared
with 13% at control pharmacies [44]. Generally positive
overall results were also observed for training pro-
grammes with non-pharmacy retailers. For example, the
proportion of Nigerian patent medicine vendors recom-
mending a correct drug dose for malaria increased from
9% in 2003 to 53% in 2004 [45], and in Kenya the pro-
portion of antimalarial sales with adequate dosage
increased from 32% in 1996 to 83% 3 months after train-
ing and to 90% 6 months after training [46].
Of the 26 interventions, data on average SES of the recip-
ient population was provided for only one. Training of
private practitioners in Pakistan clearly benefited a gener-
ally poor population, with an estimated median monthly
household income of $48–72 and $48–61 in two com-
munities [47]. General information on rural/urban set-
tings was provided for 18 interventions and no
information for 7. No studies provided any evidence on
the distribution of benefits by relative SES.
Franchising
Six interventions were identified, "Green Star" and "Green
Key" in Pakistan, "Ray of Hope" in Ethiopia, "Janani" in
Bihar State, India, "Sewa" in Nepal and "Top Reseau" in
Madagascar. Evidence of impact on utilization or quality
of health services was mixed.
Effectiveness of the Pakistan, Ethiopia and Bihar interven-
tions was documented in a single study that used exit
interviews to examine client satisfaction at franchised and
non-franchised outlets [48]. Effectiveness of the "Green
Star" and "Green Key" franchises implemented in Paki-
stan was jointly evaluated. Clients attending franchised
private services were significantly more likely to report
that they would return than those attending non-fran-
chised services in Pakistan and significantly less likely in
Ethiopia, with no statistically significant difference in
Bihar. In all three settings there was no statistically signif-
icant difference between the franchise status of the clinic
and perceptions of quality (that the service was better than
others available) or in citing affordability as a preferred
feature of the service [48].
The Nepali study examined client satisfaction with quality
of care [49]. Clients at intervention clinics 'very satisfied'
with cleanliness increased from 37% to 65%, and with the
availability of essential equipment from 35% to 62% [49].
Clients were also reported to be more satisfied with the
range of services offered in the intervention clinics (40%
to 71%) and with privacy (38% to 72%) [49].International Journal for Equity in Health 2007, 6:17 http://www.equityhealthj.com/content/6/1/17
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The Top Réseau study reported that coverage of modern
contraceptives was higher for women with high exposure
to the intervention (have accessed a franchised clinic and
have been exposed to the IEC activities) than those with
low or medium exposure [50].
Data on average SES of the recipient population was pro-
vided for one of the six interventions. The Nepali fran-
chise network clearly benefited a generally poor
population, with an estimated income per capita of $125
[49].
Evidence on the socioeconomic distribution of benefits
within the recipient community was provided for the fran-
chise networks in Pakistan, Ethiopia and Bihar State. The
Green Star and Green Key interventions in urban Pakistan
did not benefit relatively poor groups. Clients with
income of $101– $250/month and with income greater
than $251 were more likely to use franchised services than
those earning less than $60/month. Clients with at least
secondary schooling were also more likely to use fran-
chised services compared to illiterate clients [48].
Evidence for the Ray of Hope intervention in Ethiopia was
mixed. Clients with income of $101–$250/month were
less likely to attend franchised services than those earning
less than $60/month. However clients with primary edu-
cation were more likely to attend franchised services com-
pared to clients with the least education [48].
The evidence from Bihar was also mixed. There was no sta-
tistically significant association between attending fran-
chised services and monthly household income [48].
Clients with no education were more likely to attend fran-
chised services compared to clients with education [48].
Only general SES information was provided for the Top
Réseau study.
Accreditation
One intervention was identified, a network of accredited
drug dispensing outlets (ADDO) implemented in rural
and peri-urban Tanzania. The accreditation process, man-
aged by the Tanzania Food Drug Authority (TFDA), aimed
to improve access to affordable and quality medicines and
pharmaceutical services through training and supervision
of outlet dispensing staff, outlet inspections, marketing
and public education [51]. The proportion of unregistered
drugs decreased in both intervention and control areas,
from 26% to 2% in the former, and from 29% to 10% in
the latter [51].
Only general information on the rural and peri-urban sta-
tus of the recipient populations was available, and no
information was provided about ADDO customers' SES.
Contracting-out
Three evaluated interventions were identified, of which
one related to contracting-out hospital services in South
Africa and two related to contracting-out primary health
care services in South Africa and Lesotho.
Contracting-out of district hospitals to private-for-profit
management was implemented in rural South Africa. The
quality of care provided by three contracted hospitals was
compared with that of three, paired public hospitals [52].
Public hospitals had better structural quality of care but
contracted hospitals had better quality of nursing care in
maternity and medical/surgical wards than public hospi-
tals, similar nursing management quality, and overall,
higher total nursing quality. No statistically significant
differences in perinatal and maternal mortality rates were
found between contracted and public hospitals [52].
General practitioners have for long been contracted on a
part-time basis to provide primary care in rural towns in
South Africa [53]. A quality of care study showed that
patients with hypertension were less likely to have their
blood pressure recorded when they sought care at con-
tracted practices than at public health facilities.
Primary care services, drugs, laboratory tests and X-rays
were provided in Lesotho to workers of a construction
company and to local communities through a contract
with a commercial medical company [53]. Overall, struc-
tural quality was similar between contracted and public
providers. However, 37% of STI cases were treated cor-
rectly by contracted providers compared with 59% and
96% of cases treated in "large" and "small" public health
facilities respectively.
Of the 3 evaluated interventions, data on the average SES
of the recipient community was provided for 2. The indi-
vidual GP and the company contract interventions clearly
benefited generally poor users given that approximately
65% to 78% of them had an estimated household
monthly income of less than $66 [53].
For the intervention to contract out district hospitals, rural
location was the only information about SES provided.
Discussion
This paper has reviewed through an "equity lens" [54] the
results of a systematic literature review of the ways of
working with for-profit providers of health services and
public health commodities to improve the utilization and
quality of essential health services, focusing specifically
on the extent to which these interventions have been dem-
onstrated to improve quality and utilization for poor and
disadvantaged groups. This focus on whether the poor
benefit is particularly important as programmes whichInternational Journal for Equity in Health 2007, 6:17 http://www.equityhealthj.com/content/6/1/17
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work with private for-profit providers might be expected a
priori to be pro-rich, since they generally require out-of-
pocket payment (except in the case of a 100% value
voucher). Available data indicate that poor people make
significant use of the private sector, and that the quality of
services they receive is at best variable. While a case can be
made, therefore, for using public funds to work with for-
profit providers, there is a need for much stronger evi-
dence that such interventions can lead to health improve-
ments for poor people.
The review confirms that international interest in working
with the private sector has been translated into a signifi-
cant number of innovative schemes. A total of 2483 refer-
ences retrieved from our initial search of the published
and grey literature related to one or more of 8 different
areas of intervention (social marketing, vouchers, pre-
packaging of drugs, franchising, accreditation, regulation,
training and contracting-out). These interventions were
implemented in a wide range of settings, and addressed a
variety of different health problems.
Yet despite this large number of studies, relatively few
qualified for inclusion as impact evaluations. In seeking
to find evidence of impact we took a more liberal position
than that of the EPOC group of the Cochrane Collabora-
tion [55], and included any studies that had employed
either a pre-post, controlled or pre-post with control
design, with or without randomisation. We do not feel,
therefore, that we have been overly rigid in our standards
of "rigour" in evaluation design. However, even using
these relatively loose criteria, it is clear that the ability of
these interventions to produce a significant impact on
quality and utilization of care is far from fully demon-
strated.
Even fewer studies (5 interventions in total) reported data
on the average SES of populations served, and therefore,
of the beneficiaries of any improvements in quality or uti-
lisation of care. However, although detailed data were
lacking in the majority of studies, it is evident that many
interventions have worked successfully in poor communi-
ties. For example, even where specific information about
SES is not provided, rural districts in low-income coun-
tries are very likely to contain populations defined as
absolutely poor by any standards and successful interven-
tions in these contexts are likely to produce equity
improvements.
We deliberately sought information about the socioeco-
nomic distribution of benefits across socioeconomic
groups and found information available for only 5 inter-
ventions. Strong evidence of benefits favouring the poor-
est was provided by the two ITN interventions (social
marketing of ITNs in Tanzania and vouchers in Zambia),
both of which used the private retail sector for distribu-
tion. In the case of Zambia, full value vouchers were pro-
vided so no out-of-pocket payment was required. In the
Tanzanian programme, significantly pro-poor results for
ITN coverage were achieved even though users were pay-
ing near-market prices for ITNs. Both these interventions
operated at a relatively small scale and more evidence is
needed of effectiveness at scale. Information about rela-
tive equity improvements was provided by the three fran-
chising interventions, for which the socioeconomic
distribution of impact was more mixed, with positive
equity effects shown in some but not all programmes.
This is difficult to explain without knowing more about
the specific features of the interventions and study con-
texts. However, we can speculate that by targeting for-
mally trained for-profit providers, the potential impact on
the poorest is lessened and that positive equity effects
might require targeting those providers predominantly
used by poor people. Formative research is therefore
needed to identify which providers are used by poor peo-
ple and why, focusing on various dimensions of accessi-
bility (geographic, social and financial). Where financial
accessibility is a critical constraint, an assessment of alter-
native subsidy mechanisms should be considered (e.g.
cash transfers, vouchers, provider subsidies).
The review identified a number of limitations of the liter-
ature, some of which have been alluded to already. First,
there are few evaluations of impact that allow robust con-
clusions to be drawn. This is not surprising as many inter-
ventions were not set up as research exercises, and
evaluation therefore had to fit around other implementa-
tion priorities. We do not wish to imply that other types
of study are not of value, especially those which focus on
description and analysis of implementation process.
However, better evidence of impact is needed [56]. Other
weaknesses of study design included limited justification
for selection of control groups and few attempts to iden-
tify and control for potential confounders. Second, very
few studies presented information about the SES of the
target population or of programme beneficiaries. Among
those studies included in the review, varied SES measures
were used, hampering comparison of results across con-
texts. Finally, many studies assess relatively short-term
effects under controlled conditions, leaving the long term
impact and sustainability of the interventions open to
question.
Finally our review had limitations. First, we searched only
English and French language literature, and used search
engines and databases that primarily index English lan-
guage sources; for grey literature we restricted our search
to sources that were web-accessible. Secondly, we encoun-
tered some difficulties in classifying interventions since
many employ a mix of approaches, for instance socialInternational Journal for Equity in Health 2007, 6:17 http://www.equityhealthj.com/content/6/1/17
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marketing and pre-packaging of drugs, or vouchers and
training providers. We sought to classify studies by pri-
mary or main intervention. However, it should be noted
that interventions included under the same sub-heading
are in reality highly heterogeneous. Moreover, with com-
plex interventions such as these, the context is likely to
have a strong influence on both the manner of implemen-
tation and the intervention's success, meaning that any
generalisation should be undertaken cautiously [11].
Finally, our conception of poverty is limited. We focused
primarily on SES, but there are other dimensions of disad-
vantage that might be important, such as gender, ethnic-
ity, and epidemiological vulnerability.
These limitations notwithstanding, practical suggestions
for future work can be identified:
• The general SES and other features of the recipient com-
munity must be reported in order to assess whether results
can be generalized across contexts.
• The socioeconomic distribution of programme benefits
should be examined whenever possible. Measuring SES is
challenging: income or expenditure are difficult to meas-
ure accurately, and may not capture the main dimensions
of vulnerability; proxies such as asset indices are easier to
collect but may raise other methodological and empirical
difficulties [57]. Moreover, the benefits of assessing SES
must be weighed against the feasibility and costs of col-
lecting this information, especially where this involves
large household surveys. Where household survey data on
asset ownership are available from other sources, data on
the same assets can be collected at exit interviews with spe-
cific private providers, and clients located in the overall
SES distribution by applying asset weights from the
household survey [14,58].
• Information on relative SES must be interpreted with
care, and in light of the characteristics of the overall study
population: in a relatively homogeneous, poor setting,
beneficiaries who appear relatively better off may still be
poor in absolute terms compared with the national distri-
bution of income.
• An outcome that favours the poor does not on its own
imply such interventions are good value for money;
investments in improving quality of care in the private
sector need to be compared with the return from invest-
ment in the public sector, including the ability of such
investments to switch use away from low quality private
care to better quality public services.
In conclusion, it is not possible to prove from the availa-
ble literature that private sector interventions benefit the
poor and improve equity. However, the fact that many
such interventions have operated successfully in relatively
poor regions or poor countries indicates that it is possible
the poor do benefit significantly – the challenge for the
future is to design evaluations and report results in ways
that can assess this clearly, and indicate how equity can be
enhanced.
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